drugset / Trial / NCT04105959
A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model
RandomizedCrossoverSingle-blindTreatment
Summary
A Randomised, Single-Blind, Placebo-Controlled, Crossover Study to Investigate the Effects of RIST4721, a Novel CXCR2 Inhibitor, on the Inflammatory Response in Healthy Male Subjects Using a Standardized Blister Model
Timeline
- Start
- 2019-07-25
- Primary completion
- 2019-11-19
- Completion
- 2019-12-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VIMNERIXIN | Small molecule | 150 mg | Oral |
| Subject | VIMNERIXIN | Small molecule | 300 mg | Oral |